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Abstract
Neuronal cell death, glial cell activation, retinal swelling and oxidative injury are complications in retinal ischemia/
reperfusion (I/R) injuries. Lycium barbarum polysaccharides (LBP), extracts from the wolfberries, are good for ‘‘eye health’’
according to Chinese medicine. The aim of our present study is to explore the use of LBP in retinal I/R injury. Retinal I/R
injury was induced by surgical occlusion of the internal carotid artery. Prior to induction of ischemia, mice were treated
orally with either vehicle (PBS) or LBP (1 mg/kg) once a day for 1 week. Paraffin-embedded retinal sections were prepared.
Viable cells were counted; apoptosis was assessed using TUNEL assay. Expression levels of glial fibrillary acidic protein
(GFAP), aquaporin-4 (AQP4), poly(ADP-ribose) (PAR) and nitrotyrosine (NT) were investigated by immunohistochemistry. The
integrity of blood-retinal barrier (BRB) was examined by IgG extravasations. Apoptosis and decreased viable cell count were
found in the ganglion cell layer (GCL) and the inner nuclear layer (INL) of the vehicle-treated I/R retina. Additionally,
increased retinal thickness, GFAP activation, AQP4 up-regulation, IgG extravasations and PAR expression levels were
observed in the vehicle-treated I/R retina. Many of these changes were diminished or abolished in the LBP-treated I/R retina.
Pre-treatment with LBP for 1 week effectively protected the retina from neuronal death, apoptosis, glial cell activation,
aquaporin water channel up-regulation, disruption of BRB and oxidative stress. The present study suggests that LBP may
have a neuroprotective role to play in ocular diseases for which I/R is a feature.
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Introduction
Many ocular diseases such as acute glaucoma and amaurosis
fugax may be associated with ischemia/reperfusion (I/R). During
I/R, there are breakdown of blood-retinal barrier (BRB),
accumulation of fluid within retina, oxidative stress and neuronal
death [1,2]. Under normal conditions, Muller cells play an
important role in maintaining water and ion homeostasis via a
variety of water and ion transport channels [1,3,4]. Aquaporin-4
(AQP4) is one of such water transport channels expressed in
Muller cells and astrocytes [5,6]. It has been shown that Muller
cells and AQP4 are involved in retinal swelling which is associated
with neuronal death [1,2].
Lycium barbarum (Gouqizi, Fructus Lycii, Wolfberry), a traditional
Chinese medicine, has been used for centuries in the East to
maintain ‘‘eye health and nourish the liver and kidney’’, and to
balance ‘‘Yin’’ and Yang’’ in the body [7]. Lycium barbarum has a
high content of polysaccharides which is approximately 40% by
dry mass; therefore studies have been focused to the liquid fraction
of the berries, the Lycium barbarum polysaccharides (LBP) [7]. LBP
is derived from an extraction process that involved the removal of
the lipid soluble components such as zeaxanthin and other
carotenoids with alcohol [8]. Previous studies have shown that
LBP can modulate the immune function [9,10], act against the
effects of aging and oxidation [11,12], protect against liver damage
[13], lower blood glucose level [14], and reduce the side effects of
chemotherapy and radiotherapy [15,16]. LBP also exerts benefi-
cial effects in animal models of ocular diseases. Previously, LBP
has been shown to protect retinal ganglion cells (RGCs) in an
animal model of chronic ocular hypertension [17]. However, the
protective effects of LBP in minimizing neuronal death, glial cell
activation, BRB disruption and oxidative stress after I/R injury
have not been investigated. Our present study aimed to determine
whether LBP could limit the damages from retinal I/R injury in
mice.
Materials and Methods
Ethics Statement
The use of animals in this study was conducted according to the
requirements of the Cap. 340 Animals (Control of Experiments)
Ordinance and Regulations, and all relevant legislation and Codes
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of Practice in Hong Kong. All the experimental and animal
handling procedures were approved by the Faculty Committee on
the Use of Live Animals in Teaching and Research in The
University of Hong Kong (CULATR #1870-09).
Animals
C57BL/6N male mice (10–12 weeks old) were used in the
present study. The animals were kept in a temperature-controlled
room with 12-hr light/12-hr dark cycle in the Laboratory Animal
Unit of The University of Hong Kong.
Pre-treatment with LBP
LBP extracts were prepared as described previously [8]. The
extracts were freeze-dried as powder for storage. For experimental
use, LBP solution was freshly prepared by dissolving the powder in
phosphate-buffered saline (PBS; 0.01 M; pH 7.4). Animals were
divided into two groups (n = 7/group) and were treated with either
PBS as the vehicle or LBP (1 mg/kg). All animals were fed orally
by gavage with either PBS or LBP once daily for 1 week prior to
the induction of retinal ischemia.
Animal model of retinal I/R
Animals were anesthetized (2% halothane in 70% N2O/30%
O2 for induction and 1% halothane in 70% N2O/30% O2 for
maintenance) and the rectal temperature were kept at 3760.5uC.
The internal carotid artery (ICA) is one of the bifurcations of the
common carotid artery and provides blood supply to the cerebral
regions. It also provides blood supply to the eye as the ophthalmic
artery is a branch of the pterygopalatine artery (PPA) which
originates from the ICA [18–21]. Unilateral retinal ischemia was
induced by inserting an 8/0 nylon monofilament coated with vinyl
polysiloxane impression material (3 M Dental Products, St. Paul,
MN) through the right external carotid artery (ECA) into the right
ICA. Both the right common carotid artery and right ECA were
ligated to avoid anastomoses between the ophthalmic artery and
the external carotid artery. Retinal ischemia was maintained for
2 hrs after which the filament was pulled out to allow reperfusion
for 22 hrs [22].
Tissue processing
Animals were sacrificed by an overdose of sodium pentobarbital
and tissue processing was performed. Eyeballs were immediately
enucleated, fixed, dehydrated and embedded in paraffin. Seven-
mm cross-sections were cut using a microtome (Microm HM 315R,
Heidelberg, Germany).
Histological evaluation
Procedures described in our recently published study were
adopted [22]. Retinal sections of the vehicle-treated eyes and the
LBP-treated eyes were deparaffinized and stained with hematox-
ylin and eosin (H&E). Four pictures, two from central (100 mm
from the optic nerve head) and two from peripheral retina
(100 mm from the peripheral end of retina) of each retinal section
were captured. The field size of each picture was approximately
0.07 mm2. Viable cells in ganglion cell layer (GCL) of the central
and peripheral retina were counted. Cells with pyknotic nuclei
were regarded as dead cells and were not counted in the counting.
Retinal swelling in our I/R model has been shown to be due to the
increase in inner retinal thickness [23]; therefore, retinal swelling
was assessed by measuring the inner retinal thickness from the
inner limiting membrane (ILM) to the inner nucleus layer (INL).
For consistency, only retinal sections with optic nerve stumps were
used [22].
Terminal deoxynucleotidyl transferase biotin-dUTP nick
end labeling (TUNEL)
Apoptosis was examined by TUNEL assay (DeadEnd Fluoro-
metric TUNEL system, Promega, Madison, WI) as previously
described [22]. To verify the TUNEL staining was localized in the
nucleus, sections were counterstained with 4,6-diamidino-2-
phenylindole (DAPI) after the reaction. Four pictures (two from
the central and two from the peripheral retina) were captured from
each retinal section. The field size of each picture was
approximately 0.07 mm2. TUNEL-positive nuclei in both GCL
and inner nuclear layer (INL) were counted.
Immunohistochemistry (IHC)
Antigen retrieval was performed by incubation with proteinase
K following deparaffinization of sections. Non-specific binding
sites were blocked with normal goat serum for 1 hr at room
temperature and then incubated with primary antibodies listed in
Table 1 overnight at 4uC. Procedures of signal detection were
adopted from our previous studies [22,23]. Semi-quantitative
analysis was carried out to assess the immunoreactivity [24,25].
Slides were randomly coded and examined in a double-blinded
approach. IHC scores were given according to the intensity as well
as the number of cells and synaptic terminals stained. Score 1
represented the weakest immunoreactivity while score 5 indicated
the highest immunoreactivity. Photomicrographs were captured
under a light microscope (Eclipse 80i; Nikon, Tokyo, Japan)
equipped with a digital camera (Diagnostic Instruments, Inc.,
Sterling Heights, MI).
IgG extravasations
Sections were blocked with Mouse on Mouse (MOM) blocking
solution (MOM kit, Vector Laboratories, Burlingame, CA) and
incubated with mouse biotinylated anti-mouse IgG secondary
antibody (MOM kit) as previous described [26]. Signal was
visualized by Vectastain ABC kit (Vector Laboratories) with 3.39-
diaminobenzidine tetrahydrochloride (Zymed, South San Fran-
cisco, CA). Leaky vessels were defined as vessels with immuno-
positive IgG signals seen outside the endothelial vessel lining. The
number of leaky and non-leaky blood vessels in the GCL and the
outer plexiform layer (OPL) were counted.
Study design and statistical analysis
The right eye of each animal was subjected to I/R, and the left
eye was used as a non-ischemic control. The retinae of right eyes
from animals pre-treated with vehicle were compared with those
from the non-ischemic control left eyes of both groups. The retinae
of right eyes from animals pre-treated with LBP were compared
with those from animals pre-treated with vehicle. A double-
blinded approach was used in all the experimental procedures,
including cell counting and data analyses. Data were presented as
mean 6 SEM. One-way Analysis-of-variance (ANOVA) followed
by the Bonferroni multiple comparison tests (Prism v4.0,
GraphPad Software, Inc., San Diego, CA) was used in cell
counting and IgG extravasations quantification. Kruskal-Wallis
Test followed by the Dunn’s multiple comparison tests (Prism v4.0)
was performed in the semi-quantitative analyses of IHC scores.
Statistically significant difference was set at p,0.05.
Results
Ganglion cell layer
2-hr ischemia followed by 22-hr reperfusion caused severe
tissue damage in the vehicle-treated retina. Many cells in the
LBP Protects Retina from I/R Injury
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GCL and INL were pyknotic in the central and peripheral retina
(Fig. 1B & 1E). The number of viable cells in GCL of the central
and the peripheral retina was significantly lower in the vehicle-
treated I/R mice compared with that in the non-ischemic control
mice (central retina: 51.6611.3 vs. 96.666.8 cells/mm, p,0.01;
peripheral retina: 42.1610.3 vs. 91.664.0 cells/mm, p,0.001)
(Fig. 1G). However, pre-treatment of LBP diminished the damage
of I/R (Fig. 1C & 1F). The number of viable cells in GCL in the
central and the peripheral retina was higher in the LBP-treated
I/R mcie compared with that in the vehicle-treated I/R mice
(central retina: 94.465.9 vs. 51.6611.3 cells/mm, p,0.05;
peripheral retina: 78.164.6 vs. 42.1610.3 cells/mm, p,0.01)
(Fig. 1G).
Retinal thickness
There was an increase in inner retinal thickness of the central
retina in the vehicle-treated mice as compared with that in the non-
ischemic control mice (central retina: 124.065.9 vs. 103.465 mm,
p,0.01; peripheral retina: 83.166.7 vs. 78.765.4 mm, p.0.05)
(Fig. 1H). On the other hand, there was a decrease in inner retinal
thickness of the central retina in the LBP-treated I/R mice as
compared with the vehicle-treated I/R mice (central retina:
103.865.0 vs. 124.065.9 mm, p,0.05; peripheral retina:
84.264.7 vs. 83.166.7 mm, p.0.05) (Fig. 1H).
Apoptosis in GCL & INL
Ischemia leads to apoptosis in the retina. More TUNEL-
positive cells were observed in the GCL of the vehicle-treated I/R
retina compared with that of the non-ischemic control retina
(37.564.5 vs. 0 cells/mm, p,0.001) (Fig. 2B & 2J) and similarly
in the INL (47.966.5 vs. 0 cells/mm, p,0.001) (Fig. 2B & 2K).
Fewer apoptotic cells were found in GCL of the LBP-treated I/R
retina when compared with that of the vehicle-treated I/R retina
(2.461.4 vs. 37.564.5 cells/mm, p,0.001) (Fig. 2C & 2J).
Slightly fewer TUNEL-positive cells were found in the INL of the
LBP-treated I/R retina when compared with that of the vehicle-
treated I/R retina; the difference however was not statistically
significant (26.568.4 vs. 47.966.5 cells/mm, p.0.05) (Fig. 2C &
2K).
Bipolar cells
PKC-a is a marker for rod bipolar cells. Normally, the cell
bodies of PKC-a-positive bipolar cells are located in the outer
border of INL and their axons terminate at the inner border of
IPL [27,28]. The expression of PKC-a after retinal I/R was
assessed semi-quantitatively using IHC score. The IHC scores in
the vehicle-treated I/R retina, the LBP-treated I/R retina and
non-ischemic control retina were 2.360.6, 4.860.2 and 5.060
arbitrary units, respectively (Fig. 3J). In other words, the
expression of PKC-a in the vehicle-treated I/R retina was less
when compared with that of the non-ischemic control retina
(Fig. 3B). However, PKC-a expression in the LBP-treated I/R
retina was more when compared with that in the vehicle-treated I/
R retina (Fig. 3C).
Amacrine cells
In non-ischemic control retina, calretinin-positive amacrine cells
were present in GCL and the innermost layer of INL. The
synaptic terminals of amacrine cells formed three distinct strata in
IPL (Fig. 3D). In the vehicle-treated I/R retina, when compared
with the non-ischemic control retina, the expression of calretinin
appeared to be less in the two cellular layers; in addition, the
innermost stratum in IPL appeared to be disorganized (Fig. 3E). In
the LBP-treated I/R retina, when compared with the vehicle-
treated I/R retina, the expression of calretinin appeared to be
more; the three strata in IPL were present and distinct in the inner
retina (Fig. 3F). The IHC scores in the vehicle-treated I/R retina,
the LBP-treated I/R retina and the non-ischemic control retina
were 2.560.5, 4.860.2 and 4.860.2 arbitrary units, respectively
(Fig. 3K).
In the normal retina, a small population of amacrine cells
expresses nNOS [28]. There were fewer nNOS-expressing
amacrine cells found in the vehicle-treated retina as compared
with the non-ischemic control retina (0.760.3 vs. 3.060.2 cells/
mm, p,0.001) (Fig. 3H & 3L). There were more nNOS-
expressing amacrine cells found in the LBP-treated I/R retina as
compared with the vehicle-treated I/R retina (1.860.3 vs.
0.760.3 cells/mm, p,0.05) (Fig. 3I & 3L).
Immunoreactivity of glial fibrillary acidic protein (GFAP)
In non-ischemic control retina, the expression of GFAP was
confined to astrocytes in GCL (Fig. 4A). In the vehicle-treated I/R
retina, GFAP immunoreactivity was markedly increased and was
not just confined to the GCL but also found in the Muller cell
processes (Fig. 4B). In the LBP-treated retina, in contrast to the
vehicle-treated I/R retina, GFAP immunoreactivity was not
increased (Fig. 4C). The IHC scores in the vehicle-treated I/R
retina, the LBP-treated I/R retina and the non-ischemic control
retina were 4.160.3, 2.360.5 and 1.560.3 arbitrary units,
respectively (Fig. 4D).
Immunoreactivity of AQP4
In the non-ischemic control retina, there was a weak
immunoreactivity of AQP4 expressed in the astrocytic end-feet
at the ILM and in the perivascular regions at the outer border of
INL (Fig. 5A). The AQP4 staining was discontinuous along the
Table 1. Primary antibodies.
Primary antibody name Dilution Catalogue # Source
Aquaporin-4 1:500 AB3594 Millipore
Calretinin 1:1000 sc-11644 Santa Cruz Biotech.
Glial fibrillary acidic protein (GFAP) 1:500 Z0334 Dako
Neuronal nitric oxide synthase (nNOS) 1:1000 07-571 Upstate Biotech.
Nitrotyrosine (NT) 1200 06-284 Upstate Biotech.
Poly(ADP-ribose) (PAR) 1:200 ALX-804-220 Alexis
Protein kinase C-a (PKC-a) 1:1000 sc-208 Santa Cruz Biotech.
doi:10.1371/journal.pone.0016380.t001
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Figure 1. Higher cell count and increased retinal thickness in the LBP-treated I/R retina. (A–F) Representative photomicrographs of H&E
stained retinal sections. (A–C) Central retina. (D–F) Peripheral retina. Pyknotic cells were observed in GCL (arrows in B & E) and INL (arrow heads in B &
E) of the vehicle-treated I/R retina. Fewer pyknotic cells were observed in the LBP-treated I/R retina (C & F). (G) Viable cell count in GCL. Fewer viable
cells were found in the vehicle-treated I/R retina when compared with the non-ischemic control retina (##p,0.01 in central retina; ###p,0.001 in
peripheral retina). More viable cells were found in LBP-treated I/R retina when compared with the vehicle-treated I/R retina (*p,0.05 in central retina;
**p,0.01 in peripheral retina). (H) Inner retinal thickness (from ILM to INL). There was an increase of retinal thickness in the central retina of vehicle-
treated I/R mice when compared with that in the non-ischemic control mice (##p,0.01). However, there was a decrease of retinal thickness in the
central retina of LBP-treated I/R mice when compared with that in the vehicle-treated I/R mice (*p,0.05). No change in inner retinal thickness of the
peripheral retina was observed among groups (p.0.05). Scale bar, 25 mm. I/R, ischemia/reperfusion; LBP, Lycium barbarum polysaccharides; ILM,
inner limiting membrane; GCL, ganglion cell layer; IPL, inner plexiform layer; INL, inner nuclear layer; OPL, outer plexiform layer; ONL, outer nuclear
layer.
doi:10.1371/journal.pone.0016380.g001
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blood vessels and appeared weak (Fig. 5A & 5D). In the vehicle-
treated I/R retina, AQP4 immunoreactivity surrounding retinal
vessels became more intense (Fig. 5B & 5E). In the LBP-treated
I/R retina, in contrast showed no increased expression of AQP4
expression in the astrocytic end-feet and perivascular regions
(Fig. 5C & 5F). The IHC scores in the vehicle-treated I/R retina,
the LBP-treated I/R retina and the non-ischemic control retina
were 4.060.5, 1.760.3 and 1.160.2 arbitrary units, respectively
(Fig. 5G).
Retinal blood vessel leakage
Blood vessel leakage was assessed by IgG extravasations. In the
vehicle-treated I/R retina, when compared with the non-ischemic
control, there were greater number of blood vessels with immuno-
positive IgG signals located outside the endothelial vessel lining.
These vessels were situated at the GCL (Fig. 6B & 6G) and OPL
(Fig. 6E & 6H). In the LBP-treated I/R retina, when compared
with the vehicle-treated I/R retina, there were smaller number of
blood vessels showing leakage (Fig. 6C, 6F–H).
Figure 2. Fewer apoptosis in LBP-treated I/R retina. (A–C) TUNEL. (D–F) DAPI. (G–I) Merged images of TUNEL and DAPI. Insets are magnified
views of the GCL and INL. (J, K) Quantification of TUENL-positive cells in GCL (J) and INL (K). In the vehicle-treated I/R retina (B), many TUNEL-positive
cells were observed in both GCL (J, arrows in B) and INL (K, arrow heads in B) when compared with the non-ischemic control retina (A) (###p,0.001).
In the LBP-treated I/R retina (C), fewer TUENL-positive cells were observed in GCL (J, ***p,0.001) when compared with the vehicle-treated I/R retina
(B). Apparently less apoptosis was noted in INL in LBP-treated I/R retina (arrow heads in C) when compared with the vehicle-treated retina (B)
although the difference is not statistically significant (K, p.0.05). Scale bars, 100 mm; Inset scale bars, 25 mm. ns, no significance.
doi:10.1371/journal.pone.0016380.g002
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Oxidative stress
Lipid peroxidation was evaluated using PAR immunohisto-
chemistry. In non-ischemic control retina, PAR expression was
limited inside the cytoplasm (Fig. 7A). A profound PAR
immunoreactivity was found inside the cell nucleus in GCL which
indicated an increased level of lipid peroxidation in the vehicle-
treated I/R retina (Fig. 7B). However, LBP pre-treatment
minimized the nucleus translocation of PAR expression (Fig. 7C).
Figure 3. Immunoreactivity of cell markers for amacrine cells and bipolar cells in the LBP-treated retina was comparable with that
in the non-ischemic control. (A–C) PKC-a Fewer cell bodies (arrow heads in B) and synaptic terminals (arrows in B) of rod bipolar cells were
observed in the vehicle-treated I/R retina compared with those in the non-ischemic control retina (A) and LBP-treated I/R retina (C). Result is
confirmed by semi-quantification of immunoreactivity of PKC-a (J). (D–F) Calretinin. Calretinin immunoreactivity was found in cell bodies of amacrine
cells in GCL (arrows in D) and INL (arrow heads in D), and synaptic terminals which form three distinct strata in the IPL (D). I/R induced neuronal
damage indicated by fewer calretinin-positive cell bodies (E) and disorganization of the strata in IPL of the vehicle-treated I/R retina (E). However, LBP
pre-treatment prevented the damage (F). (K) Semi-quantification of calretinin immunoreactivity. (G–I) Neuronal nitric oxide synthase (nNOS). A small
population of nNOS-positive amacrine cells was found in GCL (arrows in G & I) and INL (arrow heads G & I) of the non-ischemic control retina and LBP-
treated I/R retina. However, these cells were scarcely seen in vehicle-treated I/R retina (H). (L) Quantification of nNOS-positive amacrine cells.
##p,0.01, ###p,0.001 vs. non-ischemic control retina; *p,0.05, **p,0.01 vs. vehicle-treated I/R retina. Scale bar, 25 mm. IHC score,
immunohistochemistry score.
doi:10.1371/journal.pone.0016380.g003
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The IHC scores of PAR immunoreactivity in the vehicle-treated
I/R retina, the LBP-treated I/R retina and the non-ischemic
control retina were 4.060.4, 2.560.4 and 2.260.4 arbitrary units,
respectively (Fig. 7G).
NT is a marker for nitrosative stress. Minimal NT immunore-
activity was noted in non-ischemic control retina (Fig. 7D). An
increased level of NT expression was seen in the vehicle-treated I/
R retina (Fig. 7E). However, LBP pre-treatment could not lower
the NT expression in I/R retina (Fig. 7F). The IHC scores of NT
immunoreactivity in the vehicle-treated I/R retina, the LBP-
treated I/R retina and the non-ischemic control retina were
3.560.4, 3.360.3 and 1.360.2 arbitrary units, respectively
(Fig. 7H).
Discussion
BRB disruption, glial cell activation, oxidative stress and
neuronal death are major concerns in retinal I/R injury.
Neuroprotective agents that can retard or prevent these damages
are beneficial in treating many ocular diseases in which retinal I/R
is a complication. In our present study, we showed that pre-
treating mice with LBP for 1 week could protect the animals from
I/R injury by reducing neuronal cell death, retinal swelling, glial
activation, BRB disruption and oxidative stress.
In the present study, unilateral retinal ischemia was induced
by occluding the ICA which supplies blood to the ophthalmic
artery [18,19]. This model is one of the commonly used animal
retinal I/R models [20,21,29]. Different from other retinal I/R
model, the unilateral ICA occlusion model is a purely vascular
model and does not involve any mechanical injury to the eye
during the experimental operation [29]. The ophthalmic artery
occlusion and blood resupply by ECA and ICA can be easily
monitored by the duration of filament kept inside the vessel
lumen. This model induces complete but reversible retinal
ischemia injury [29] and leads to a considerable cell loss in inner
retina by the blockade of ophthalmic artery [21–23,30]. It
mimics the clinical situation of transient monocular amaurosis
fugax [21,29] and other ocular diseases in which retinal I/R is a
complication. Therefore, this artery occlusion model is a good
tool for exploring neuroprotective agents against retinal I/R
injury.
Lycium barbarum is a dried fruit that is used as a food or a
medicine according to Chinese tradition [7]. It has been claimed
that LBP can exhibit anti-aging, anti-tumor, cytoprotective, neuro-
Figure 4. Lower level of glial fibrillary acidic protein (GFAP) activation in the LBP-treated I/R retina. (A–C) Immunohistochemistry of
GFAP. I/R induced intense GFAP immunoreactivity in Muller cell processes of the vehicle-treated I/R retina (arrows in B), but not of the LBP-treated I/R
retina (C). Results were confirmed by semi-quantification of IHC in (D). ##p,0.01 vs. non-ischemic control retina; *P,0.05 vs. vehicle-treated I/R
retina. Scale bar, 25 mm.
doi:10.1371/journal.pone.0016380.g004
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modulation, and immune modulation effects [7]. LBP can
attenuate breakage of DNA by oxidation in the testicle cells in
mice [31]. It has also been shown to protect DNA damage of
peripheral blood lymphocytes against oxidative stress [32].
However, researches on the protective effects of LBP against
ocular diseases are still ongoing. In the present study, we aim to
look at the protective effects of LBP against retinal I/R injury. We
focus on four aspects that are closely related to retinal I/R injury:
anti-apoptosis, preservation of BRB integrity, prevention of retinal
swelling, and anti-oxidation.
Retinal I/R induces neuronal death in the inner retina,
especially RGC. An extensive loss of cells in the GCL has been
seen after retinal I/R injury [21,22]. A majority of these neurons
die by apoptosis during retinal I/R injury [33]. Our data show an
increased number of apoptotic nuclei in inner retinal layers,
especially in the GCL, of the ischemic retina. The result is highly
reproducible and comparable to our previously published data
[22]. In previous studies, only a few TUNEL-positive apoptotic
cells are found in inner retina with 1 hr ischemia injury although
similar animal model is used [21,30]. The discrepancy is probably
Figure 5. Lower level of aquaporin-4 (AQP4) immunoreactivity in the LBP-treated I/R retina. (A–C) Photomicrographs taken with a 40x
objective. (D–F) Photomicrographs taken with a 60x objective. In the non-ischemic control retina, mild AQP4 immunoreactivity was observed in the
astrocytic end-feet in ILM and perivascular regions near INL (A & D). However, intense AQP4 immunoreactivity was seen in the astrocytic end-feet in
ILM and perivascular regions of the vehicle-treated I/R retina (B & E). However, the AQP4 immunoreactivity in LBP-treated I/R retina was comparable
with that in the non-ischemic control retina (C & F). Results were further confirmed by the semi-quantitative analysis (G). ##p,0.01 vs. non-ischemic
control retina, *p,0.05 vs. vehicle-treated I/R retina. Scale bar for A–C, 25 mm. Scale bar for D–F, 15 mm.
doi:10.1371/journal.pone.0016380.g005
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due to the shorter ischemia period when compared with that in
our study. Retinal function, assessed by the a-wave and b-wave of
electroretinography, is deteriorated in the ischemic eye [29],
suggesting that the function of retinal neurons is weakened in
retinal I/R injury. Similar to a previous study [34], we also show
that retinal I/R caused detrimental injury to amacrine cells, as
indicated by the great reduction in calretinin expression and the
dis-organization of IPL stratification. Apart from calretinin-
expressing amacrine cells, fewer nNOS-expressing amacrine cells
were observed in I/R retina [22,35,36]. Comparable phenomenon
was noted in bipolar cell immunoreactivity in the present study.
Apart from neuronal damage, I/R injury also induces impairment
in synaptic connections of retinal neurons [30]. Vesl-1L/Homer
1c (V-1L) is a marker for used as a marker for the assessment of
changes in synaptic connectivity preceding apoptosis and during
early stages of apoptosis of RGCs [30]. A reduction of V-1L
immunoreactivity indicates that the synaptic connections of RGCs
and other inner retinal neurons, including amacrine cells and
bipolar cells, are attenuated after I/R. In this study, our first aim
to investigate the anti-apoptotic and neuroprotective effects of LBP
in retinal I/R injury. Significantly fewer apoptotic cells were seen
in GCL and INL of LBP-treated ischemic retina. The detrimental
effects on amacrine cells and bipolar cells due to I/R injury was
minimized. In outer retina, LBP has been shown to decrease
apoptosis in photoreceptors of rd1 mice with photoreceptor
degeneration [37]. Its beneficial protection is as good as other
neuroprotective agents such as lutein and zeaxanthin
[22,37,38,39,40]. Our data elucidated that LBP is anti-apoptotic
not only in outer retina, but also inner retina. Moreover, our
earlier studies showed that LBP protects against beta-amyloid
peptide neurotoxicity by inhibiting pro-apoptotic signaling path-
ways such as JNK, PKR and caspase-3 [8,12]. It is therefore likely
that LBP may exert its neuroprotective effects via inhibition of
JNK, PKR and caspase-3 activity in retinal I/R injury.
Figure 6. The number of leaky blood vessels in the LBP-treated I/R retina was comparable with that in the non-ischemic control
retina. (A–C) IgG extravasations in blood vessels in GCL. (D–F) IgG extravasations in blood vessels in OPL. In non-ischemic control retina, IgG staining
was confined inside the blood vessel lumen demarcated by endothelial cells (arrows in A & D). However, I/R induced blood vessel leakage in both GCL
and OPL (arrow heads in B & E) in the vehicle-treated I/R retina but not in the LBP-treated I/R retina (arrows in C & F). (G, H) Quantification of blood
vessel leakage in GCL (G) and OPL (H). More leaky blood vessels were observed in GCL (G) and OPL (H) of the vehicle-treated I/R retina. However, LBP
treatment decreased the I/R-induced blood vessel damage, evident from fewer leaky blood vessels. ###p,0.001 vs. non-ischemic control retina;
**p,0.01, ***p,0.001 vs. vehicle-treated I/R retina. Scale bar, 25 mm.
doi:10.1371/journal.pone.0016380.g006
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Figure 7. LBP pre-treatment lowered lipid peroxidation but not nitrosative stress in I/R retina. (A–C) Immunohistochemisty of poly(ADP-
ribose) (PAR). PAR expression was localized in the cytosol of cells of the non-ischemic control retina and LBP-treated I/R retina (arrow heads in A & C).
However, PAR expression was found inside the cell nuclei of the vehicle-treated retina (arrow in B). (D–F) Immunohistochemistry of nitrotyrosine (NT).
A minimal NT expression was seen in the non-ischemic control retina (D). However, an increased level of NT immunoreactivity was noted in the
vehcle-treated I/R retina and LBP-treated I/R retina (E & F). Results were confirmed by semi-quantification of IHC (G, PAR; H, NT). #p,0.05 vs. non-
ischemic control retina; *P,0.05 vs. vehicle-treated I/R retina. Scale bar, 25 mm.
doi:10.1371/journal.pone.0016380.g007
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BRB is a protective barrier which consists of the outer and inner
BRB. The role of BRB is to maintain the homeostatic condition of
retinal microenvironment and exclude harmful substance getting
into the retina [41,42]. The outer barrier is formed by the retinal
pigment epithelium, separating the outer retina from the choroid
[43]. The inner BRB is formed by the tight junctions of the
vascular endothelial cells and sheathed by the Muller cell processes
[43,44]. In many ocular disease including ischemic retinal vein/
artery occlusion and diabetic retinopathy, breakdown of the inner
BRB increases retinal vascular permeability, resulting in retinal
edema and cell death [26,42,45]. In the present study, we
examined BRB integrity by assessing blood vessel leakage using
IgG immunohistochemistry. The majority of IgG was confined in
the lumen of blood vessels in normal retina. However, IgG
extravasations were present outside the vessel lumen after I/R
injury, indicating blood vessel leakage and BRB breakdown. IgG
extravasations was minimized in ischemic retina treated with LBP.
This suggests that LBP could prevent or minimize the disruption
of BRB in retinal I/R injury, which has not been studied
previously.
Disruption of BRB leads to swelling of astrocytes and Muller
cells processes associated with the activation of GFAP and AQP4
under ischemic conditions [41,42]. These causes further retinal
edema and tissue damage. In normal conditions, water and ion
homeostasis in retina is controlled by Muller cells via the
transmembrane aquaporin water channels [6,46]. Muller cells
do not express GFAP under normal physiological situations. The
end feet of retinal astrocytes and Muller cells wrap around the
blood vessels of the superficial retina and express AQP4 [2,6,46].
GFAP up-regulation is a hallmark of astrocyte and Muller cell
activation and the resulting reactive gliosis [47]. Expression of
GFAP in Muller cells and astrocytes occurs under pathological
conditions such as I/R injury [48,49]. In addition, over-expression
of AQP4 is associated with water influx into the retina during
injury [1]. Water influx is further exaggerated during reperfusion.
Swelling and hypertrophy of Muller cells occur consequently upon
overloading of intracellular K+ and the movement of water inside
cells [1,50]. It has been shown that the deletion of AQP4 gene can
protect retina against swelling in a mouse model of ischemia, thus
emphasizing the importance of AQP4 in water transport [51]. In
the present study, activation of GFAP and AQP4 was observed in
the vehicle-treated retina, indicating the role of Muller cells and
AQP4 controlling water transport in retina. Moreover, retinal
swelling was noted in ischemic retina. These results indicate a close
association among the BRB integrity, the control of water flux and
retinal swelling. Here, we show that LBP pre-treatment could
diminish the activation of GFAP and AQP4, as well as retinal
swelling in retinal I/R injury, implying the inhibitory effects of
LBP in retinal swelling by minimizing the activation of Muller cell
and AQP4.
Oxidative stress plays a role in retinal I/R injury due to the high
content of polyunsaturated fatty acid in retina. Reactive oxygen
species (ROS) and free radical formation during I/R facilitates
lipid peroxidation of membrane, denature of protein and DNA
damage [52,53]. The breakdown of DNA strands activates the
nuclear enzyme poly(ADP-ribose) polymerase (PARP) to produce
PAR [54]. PARP cleaves nicotinamide adenine dinucleotide, and
subsequently leads to energy failure and cell death [55,56].
Another pathway of inducing oxidative stress is the nitrosative
injury. Free radical formation facilitates nitric oxide (NO)
production, which reacts with superoxide to from peroxynitrite,
a strong oxidant [57]. Peroxynitrite leads to nitration of tyrosine
residues of cells to form NT [58,59]. Therefore, NT is an indicator
for oxidative-nitrosative stress. Increased immunoreactivity of
PAR and NT was observed in the vehicle-treated I/R retina,
indicating increased oxidative stress associated with retinal I/R. In
addition, oxidative stress has been shown to have an injurious role
in BRB integrity by disruption of tight junctions in retina [60].
ROS generated in ischemia up-regulates vascular endothelial
growth factor (VEGF) gene expression [61]. Tight junction
damage and increased VEGF expression attribute to an increase
in vascular permeability and subsequent BRB breakdown [41].
Treatment with anti-oxidants, including Lycium barbarum, increases
glutathione peroxidase activity and glutathione levels, and
decreases cystine concentrations in retina of rd1/rd1 mice,
indicating a decreased level of oxidative stress in retinal generation
[37]. In the present data, LBP-treated I/R retina had a less extent
of oxidative stress, indicated by a decreased level of PAR
immunoreactivity. These findings suggest that one of the possible
mechanisms for LBP to exhibit its cytoprotective effects is via
attenuation of oxidative stress. The decrease in oxidative stress
may attribute to prevent or diminish BRB breakdown induced by
I/R injury. However, LBP treatment did not lower NT
immunoreactivity after I/R injury. This may imply that LBP
does not have anti-oxidative effect against nitrosative stress.
Further investigation is required to confirm this observation.
Increasing lines of evidence have demonstrated that modulation
of immune responses can affect the degenerative processes of
neurons in the CNS [62,63]. In fact, previous studies have shown
that LBP can enhance immune function [9,10,64], suggesting that
the beneficial effects of LBP may also be mediated by immuno-
modulations. Our recent study also demonstrated that LBP protect
RGC by modulating the activation of microglia in an animal
model of chronic ocular hypertension [65]. We speculate that
neuroprotection conferred by LBP may be a combination of many
different mechanisms including anti-apoptosis, anti-oxidation and
immuno-modulation in addition to our current findings i.e.
protection of the BRB and maintenance of the water homeostasis
via the down-regulation of AQP4.
Conclusions
Our data indicated that pre-treatment with LBP for 1 week
could effectively protect the mouse from retinal I/R injury. The
present study hence suggests that LBP may be used as a preventive
TCM for diseases associated with I/R such as amaurosis fugax
and acute glaucoma. Further studies are warranted to evaluate the
therapeutic effects of LBP and other potential neuroprotective
mechanisms.
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